Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunsik Lee

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Visualized Experiments : Jove|August 31, 2011
A mouse model of the cornea pocket assay for angiogenesis studyZhongshu Tang, Fan Zhang, Yang Li, et al.
Oncotarget|September 28, 2010
VEGF-independent angiogenic pathways induced by PDGF-CXuri Li, Anil Kumar, Fan Zhang, et al.
Cancer Research|February 21, 2006
Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoproteinJohan Dixelius, Anna-Karin Olsson, Asa Thulin, et al.
Molecular Oncology|November 30, 2019
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosisJong Kyong Kim, Guangyan Kan, Yu Mao, et al.
Journal of Visualized Experiments : Jove|May 5, 2011
An optic nerve crush injury murine model to study retinal ganglion cell survivalZhongshu Tang, Shuihua Zhang, Chunsik Lee, et al.
Cell Death & Disease|December 10, 2021
Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapyYu Mao, Yu Sun, Zhixuan Wu, et al.
Cell Adhesion & Migration|August 18, 2009
VEGF-B: a survival, or an angiogenic factor?Xuri Li, Chunsik Lee, Zhongshu Tang, et al.
Cancer Research|January 28, 2004
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularizationAnna-Karin Olsson, Helena Larsson, Johan Dixelius, et al.
Pharmacological Research|May 22, 2019
Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene setsXiangke Yin, Xianchai Lin, Xiangrong Ren, et al.
Pharmacological Research|December 12, 2025
VEGF-B: A multifaceted modulator with emerging therapeutic applicationsChunsik Lee, Myung-Jin Kim, Eunyoung Jung, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Visualized Experiments : Jove|August 31, 2011
A mouse model of the cornea pocket assay for angiogenesis studyZhongshu Tang, Fan Zhang, Yang Li, et al.
Oncotarget|September 28, 2010
VEGF-independent angiogenic pathways induced by PDGF-CXuri Li, Anil Kumar, Fan Zhang, et al.
Cancer Research|February 21, 2006
Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoproteinJohan Dixelius, Anna-Karin Olsson, Asa Thulin, et al.
Molecular Oncology|November 30, 2019
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosisJong Kyong Kim, Guangyan Kan, Yu Mao, et al.
Journal of Visualized Experiments : Jove|May 5, 2011
An optic nerve crush injury murine model to study retinal ganglion cell survivalZhongshu Tang, Shuihua Zhang, Chunsik Lee, et al.
Cell Death & Disease|December 10, 2021
Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapyYu Mao, Yu Sun, Zhixuan Wu, et al.
Cell Adhesion & Migration|August 18, 2009
VEGF-B: a survival, or an angiogenic factor?Xuri Li, Chunsik Lee, Zhongshu Tang, et al.
Cancer Research|January 28, 2004
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularizationAnna-Karin Olsson, Helena Larsson, Johan Dixelius, et al.
Pharmacological Research|May 22, 2019
Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene setsXiangke Yin, Xianchai Lin, Xiangrong Ren, et al.
Pharmacological Research|December 12, 2025
VEGF-B: A multifaceted modulator with emerging therapeutic applicationsChunsik Lee, Myung-Jin Kim, Eunyoung Jung, et al.
Pageof 4